Instant NanoBiosensors - Taipei, Taiwan

In August 2016, Instant NanoBiosensors Co., Ltd. was established with operation sites in Taipei and the USA. Since then, the company has employed more than a dozen professionals, including experts in biology, microfluidics, chemistry, machinery, software and hardware integration, AI algorithms, marketing and business development. In May 2019, our Light Sensing Biomarker Analyzer was launched and won its first overseas order from Brigham and Women's Hospital (BWH), a teaching hospital of Harvard Medical School. We have also been working with BWH in clinical studies. In 2020, Instant NanoBiosensors was chosen as one of the twelve most innovative young companies for worldwide strategic collaboration by Merck KGaA, from a pool of 500 candidates from around the world. This was due to our  

Show more

unique fiber optic microfluidic nano-chip technology, which is capable of analyzing proteins and nucleic acids quickly and accurately, similar to the accuracy of top laboratories.

Biomarkers are widely used by researchers and clinicians alike as research and clinical tools. However, many biomarkers are not detectable using conventional technologies, resulting in narrow detection ranges that can only reflect more advanced disease conditions. To support advanced medical research and early disease diagnosis, the biomarker detection range must be widened. Our platform utilizes patented Fiber Optic Particle Plasmon Resonance (FOPPR™) and IN-Chip (auto-flowing microfluidic